Global Urethral Strictures Market Research Report Forecast Till 2023

$4,450$6,250

Global Urethral Strictures Market Research Report Information: Type (AUS, PUS) Condition (Hypospadias & Epispadias) Cause (Idiopathic) Treatment (Urethroplasty) Gender (Male, Female) End-user (Ambulatory Surgical Centers) – Forecast Till 2023

Clear

Description

Introduction
Urethral stricture refers to the narrowing of the urethra. This disease causes an inflammation of the urethra that narrows or
blocks the passageway through which the urine flows from the bladder. The stricture could be caused
due to inflammation, infection, or injury. It is much more common in men than in women. The
urethral stricture market could be driven by the increasing prevalence of urethral strictures, rising
cases of urolithiasis in the adult population, and the growing incidence of urinary incontinence.
Hypospadias is a common congenital malformation that requires surgical repair, and its long-term management requires a substantial amount of socioeconomic resources. The rising prevalence of hypospadias is of major interest for healthcare providers, clinical medicines, and research. According to a study published by the NCBI in 2016, the mean prevalence for hypospadias in North America was 34.2, followed by 19.9 in Europe, 0.6 to 69 in Asia, and 5.9 in Africa.
The global urethral stricture market is segmented based on type, condition, cause, treatment, gender, and end user.
On the basis of type, the market has been segmented into posterior urethral stricture and anterior urethral stricture.
The global urethral stricture market on the basis of cause is divided into hypospadias and epispadias and urinary incontinence.
Based on condition, the market is further segmented into iatrogenic, idiopathic, infection-induced, and trauma.
The treatment segment is classified into urethral dilation, direct vision internal urethrotomy (DVIU), and urethroplasty.
Based on gender the market has been divided into male and female.
Based on end user, the market is segmented into hospitals, urologic clinics, and ambulatory surgical centers.
The global urethral stricture market was valued at USD 934.7 million in 2017 and is expected to register a CAGR of 7.30% over the forecast period.
Key Players
SRS Medical, JenaSurgical GmbH, Boston Scientific Corporation, Cook Medical, Stryker Corporation, KARL STORZ GmbH & Co. KG, Olympus Corporation, PENTAX Medical, Healthtronics Inc, Allium Medical Solutions, UROMED, Richard Wolf GmbH, Bard Medical, Lumenis Ltd, and Mukocell
Study objectives
To provide a detailed analysis of the market structure along with a forecast of various segments and sub-segments of the global urethral stricture market
• To provide insights into factors influencing and affecting the market growth
• To provide historical and forecast revenue of market segments and sub-segments with respect to countries
• To provide strategic profiling of key players in the market, and comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market
• To provide economic factors that influence the global urethral stricture market
• To provide a detailed analysis of the value chain and supply chain of the global urethral stricture market
Target Audience
• Medical Devices Manufacturers
• Medical Devices Distributors
• Research and Development (R&D) Companies
• Market Research and Consulting Service Providers
• Potential Investors
Key Findings
• The global urethral stricture market is expected to reach 934.7 Million by 2024 at a CAGR of 7.30% from 2018 to 2024
• On the basis of type, the posterior urethral stricture segment accounted for the major market share of 54.02% and was valued at USD 504.9 million in 2017
• Based on condition, the hypospadias and epispadias segment accounted for the major market share of 50.15% and was valued at USD 468.8 million in 2017
• On the basis of treatment, the urethroplasty segment accounted for the major market share of 35.70% and was valued at USD 333.7 million in 2017
• On the basis of cause, the idiopathic segment accounted for the major market share of 35.6% and was valued at USD 333.6 million in 2017
• On the basis of end user, the hospitals segment accounted for a major market share of 35.6% in 2017 with USD 333.6 million in 2017
• The Americas is expected to hold the largest share of the global urethral stricture market which is expected to reach USD 534.3 million by 2024
• Asia-Pacific is the fastest growing market, which is expected to register a CAGR of 7.92% from 2018 to 2024
Regional Analysis
• Americas
o North America
 US
 Canada
o South America
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Australia
o Republic of Korea
o Rest of Asia Pacific
• Middle East & Africa
o Middle East
o Africa

Table of Contents

Table of Contents:

1 Executive Summary
2 Market Introduction
2.1 Scope of Study
2.2 Research Objective
2.3 List of Assumptions
2.4 Market Structure
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4 Market Dynamics
4.1 Drivers
4.1.1 Introduction
4.1.2 Increasing prevalence of urethral strictures
4.1.3 Rising cases of urolithiasis in the adult population
4.1.4 Growing occurrence of urinary incontinence
4.2 Restraints
4.2.1 High cost of surgical procedure
4.2.2 High rate of complications
4.3 Opportunities
4.3.1 Technologically advanced products
5 Market Factor Analysis
5.1 Porter’s Five Forces Model
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.2.1 Research &Development
5.2.2 Manufacturing
5.2.3 Distribution
5.2.4 Marketing & Sales
5.2.5 Post-Sales Monitoring
5.3 Epidemiology of Urethral Stricture
6 Global Urethral Stricture Market, By Type
6.1 Introduction
6.1.1 Posterior Urethral Stricture
6.1.2 Anterior Urethral Stricture
7 Global Urethral Stricture Market, By Condition
7.1 Introduction
7.1.1 Hypospadias & Epispadias
7.1.2 Urinary Incontinence
8 Global Urethral Stricture Market, By Cause
8.1 Introduction
8.1.1 Iatrogenic
8.1.2 Idiopathic
8.1.3 Infection-induced
8.1.4 Trauma
9 Global Urethral Stricture Market, By Treatment
9.1 Introduction
9.1.1 Urethral Dilation
9.1.2 Direct Vision Internal Urethrotomy (DVIU)
9.1.3 Urethroplasty
10 Global Urethral Stricture Market, By Gender
10.1 Introduction
10.1.1 Male
10.1.2 Female
11 Global Urethral Stricture Market, By End User
11.1 Introduction
11.1.1 Hospitals
11.1.2 Urologic Clinics
11.1.3 Ambulatory Surgical Centers
12 Global Urethral Stricture Market, By Region
12.1 Introduction
12.2 Americas
12.2.1 North America
12.2.1.1 U.S.
12.2.1.2 Canada
12.2.2 South America
12.3 Europe
12.3.1 Germany
12.3.2 France
12.3.3 UK
12.3.4 Italy
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia Pacific
12.4.1 Japan
12.4.2 China
12.4.3 India
12.4.4 Rest of Asia Pacific
12.5 Middle East & Africa
12.5.1 Middle East
12.5.2 Africa
13 Competitive Landscape
13.1 Company Market Share Analysis
13.1.1 Introduction
13.2 Competitive Landscape
13.2.1 Introduction
13.3 Key Developments
13.3.1 Global Urethral stricture Market: Key Development
14 Company Profiles
14.1 SRS Medical
14.1.1 Company Overview
14.1.2 Financial Overview:
14.1.3 Products Offering
14.1.4 Key Developments
14.1.5 SWOT Analysis
14.1.6 Key Strategy
14.2 JenaSurgical GmbH
14.2.1 Company Overview
14.2.2 Financial Overview:
14.2.3 Products Offering
14.2.4 Key Developments
14.2.5 SWOT Analysis
14.2.6 Key Strategy
14.3 Boston Scientific Corporation
14.3.1 Company Overview
14.3.2 Financial Overview
14.3.3 Products Offering
14.3.4 Key Developments
14.3.5 SWOT Analysis
14.3.6 Key Strategy
14.4 Cook Medical
14.4.1 Company Overview
14.4.2 Financial Overview:
14.4.3 Products Offering
14.4.4 Key Developments
14.4.5 SWOT Analysis
14.4.6 Key strategy
14.5 Stryker Corporation
14.5.1 Company Overview
14.5.2 Financial Overview:
14.5.3 Products Offering
14.5.4 Key Developments
14.5.5 SWOT Analysis
14.5.6 Key strategy
14.6 KARL STORZ GmbH & Co. KG
14.6.1 Company Overview
14.6.2 Financial Overview:
14.6.3 Products Offering
14.6.4 Key Developments
14.6.5 SWOT Analysis
14.6.6 Key strategy
14.7 Olympus Corporation
14.7.1 Company Overview
14.7.2 Financial Overview
14.7.3 Products Offering
14.7.4 Key Developments
14.7.5 SWOT Analysis
14.7.6 Key Strategy
14.8 PENTAX Medical
14.8.1 Company Overview
14.8.2 Financial Overview
14.8.3 Products Offering
14.8.4 Key Developments
14.8.5 SWOT Analysis
14.8.6 Key Strategy
14.9 Healthtronics, Inc.
14.9.1 Company Overview
14.9.2 Financial Overview
14.9.3 Products Offering
14.9.4 Key Developments
14.9.5 SWOT Analysis
14.9.6 Key Strategy
14.1 Allium Medical Solutions
14.10.1 Company Overview
14.10.2 Financial Overview
14.10.3 Products Offering
14.10.4 Key Developments
14.10.5 SWOT Analysis
14.10.6 Key Strategy
14.11 UROMED
14.11.1 Company Overview
14.11.2 Financial Overview
14.11.3 Products Offering
14.11.4 Key Developments
14.11.5 SWOT Analysis
14.11.6 Key Strategy
14.12 Richard Wolf GmbH
14.12.1 Company Overview
14.12.2 Financial Overview
14.12.3 Products Offering
14.12.4 Key Developments
14.12.5 SWOT Analysis
14.12.6 Key Strategy
14.13 Bard Medical
14.13.1 Company Overview
14.13.2 Financial Overview
14.13.3 Products Offering
14.13.4 Key Developments
14.13.5 SWOT Analysis
14.13.6 Key Strategy
14.14 Lumenis Ltd.
14.14.1 Company Overview
14.14.2 Financial Overview
14.14.3 Products Offering
14.14.4 Key Developments
14.14.5 SWOT Analysis
14.14.6 Key Strategy
14.15 Mukocell
14.15.1 Company Overview
14.15.2 Financial Overview:
14.15.3 Products Offering
14.15.4 Key Developments
14.15.5 SWOT Analysis
14.15.6 Key Strategy
15 Appendix
15.1 Discussion Blue Print

Additional information

Publisher

Geography Covered

Date Published

Pages

Format